source
- Gilead and Merck’s latest trial success and flopAstraZeneca's GLP-1 pill, GSK's $10.6B cancer startup acquisition, and more biotech news from The ReadoutSTAT · 1mo ago↗ source
- STAT+: NIAID appoints new acting director after weekslong questions over leadershipThe NIH has appointed researcher John Powers III to lead its infectious disease institute on an acting basis, after weeks of being in leadership limbo.STAT · 1mo ago↗ source
- FDA Expands Sunscreen Options for the First Time in 20 YearsToday, the U.S. Food and Drug Administration added bemotrizinol to the list of permitted sunscreen active ingredients, marking a significant milestone in the agency's efforts to advance sunscreen i…fda press · 1mo ago↗ source